Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:
• Currently using one or more topical glaucoma antihypertensives
• Self-described symptoms of ocular surface discomfort
• Xiidra is being prescribed as part of the subject's standard care
Locations
United States
California
Doheny Eye Center UCLA
RECRUITING
Fountain Valley
Contact Information
Primary
Benjamin B Bert, MD
BBert@mednet.ucla.edu
626-817-4701
Backup
Mayra Raygoza
Mraygoza@mednet.ucla.edu
16268174747
Time Frame
Start Date: 2021-04-01
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 75
Treatments
Group 1
Xiidra (Lifitegrast ophthalmic solution) 5% applied to both eye (OU) for 12 weeks
Related Therapeutic Areas
Sponsors
Leads: University of California, Los Angeles
Collaborators: Bausch & Lomb Incorporated